Department of Psychiatry Faculty

Education

1971, B.A., Yale College
1976, M.D., Yale University School of Medicine
Residency: Yale University

Research Interest

The major focus of my clinical research has been to improve the efficacy, accessibility, and availability of substance abuse treatment through clinical trials and clinical epidemiologic studies. The general themes of my research and approaches utilized are evident in the major, interrelated programs of research that I have developed aimed at: 1. improving the efficacy of opioid agonist maintenance treatment through investigations of buprenorphine as an alternative to methadone for maintenance treatment and investigations of adjunctive behavioral (e.g., contingency management, community reinforcement approach, and behavioral drug and HIV risk reduction counseling) and pharmacological (e.g., disulfiram) treatments for co-occurring cocaine dependence, 2. improving the accessibility and effectiveness of opioid dependence treatment by integrating it in office-based and primary care settings, and 3. expanding opioid dependence treatment and clinical research in international settings. I am currently evaluating buprenorphine and naltrexone treatment of opioid dependence in clinical trials in Malaysia and Iran, evaluating behavioral and HIV risk reduction counseling and abstinence contingent take-home buprenorphine in a primary care clinic in New Haven and in Malaysia, and developing behavioral treatments for methadone maintained opioid dependent patients.

Publications of Note

Schottenfeld RS, Pantalon MV, Chawarski M, Pakes J. Community reinforcement approach for combined opioid and cocaine dependence: Patterns of engagement in alternate activities. Journal of Substance Abuse Treatment 18:255-261, 2000.

Schottenfeld RS, Pakes J, O’Connor P, Chawarski M, Oliveto A, Kosten T. Thrice weekly versus daily buprenorphine maintenance. Biological Psychiatry 47:1072-1079, 2000.

Fiellin DA, O’Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS. Methadone maintenance in primary care: A randomized controlled trial. JAMA 286:1724-1731, 2001.

Fiellin DA, Pantalon MV, Pakes JP, O’Connor PG, Chawarski M, Schottenfeld RS. Treatment of Heroin Dependence with Buprenorphine in Primary Care. American Journal of Drug and Alcohol Abuse 28(2):231-241, 2002.

Pantalon MV, Chawarski MC, Falcioni J, Pakes J, Schottenfeld RS. Linking process and outcome in the community reinforcement approach for treating cocaine dependence: A preliminary report. American Journal of Drug and Alcohol Abuse 30(2):353-368, 2004

Schottenfeld RS, Chawarski MC, Pakes J, Pantalon MV, Carroll KM, Kosten TR. Methadone vs. buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. American Journal of Psychiatry 162: 340-349, 2005.

Copyright ©2004. Yale University School of Medicine, Psychiatry Department. All rights reserved.
Comments or suggestions to the site editor.

Home URL: http://info.med.yale.edu/ysm